FLT-PET/DW-MRI for Detection of Brain Metastases and Early Therapy Evaluation in Patients With Small Cell Lung Cancer (SIBES II)

Rigshospitalet

Status: Completed

Conditions: Small Cell Lung Cancer

Treatments: Device: FLT-PET; Device: MRI

Study type: Interventional

Funder types: Other

Identifiers

NCT02995902

307_14

Details and patient eligibility

About

The purpose of the study is to determine the value of FLT-PET early after initiated chemotherapy in patients with small cell lung cancer, and to determine whether MRI of the brain should be performed routinely in these patients.

Enrollment: 13 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• biopsy proven small cell lung cancer
• referred for standard chemotherapy
• oral and written informed consent

Exclusion criteria

• metal or electronical devices in the body not compatible with MRI of brain or thorax
• pregnancy or lactation
• communication difficulties

Trial design

Primary purpose: Diagnostic

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

13 participants in 1 patient group

FLT-PET/MRI

Experimental group

Treatment:

Device: MRI

Device: FLT-PET